Synergistic effect of kaempferol glycosides purified from Laurus nobilis and fluoroquinolones on methicillin-resistant Staphylococcus aureus

Biological and Pharmaceutical Bulletin

Volumn 32, Issue 3, 2009, Pages 489-492

  Liu, Mei Hua ^a   Otsuka, Nao ^a   Noyori, Kumiko ^b   Shiota, Sumiko ^b   Ogawa, Wakano ^a   Kuroda, Teruo ^a   Hatano, Tsutomu ^a   Tsuchiya, Tomofusa ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b SHUJITSU UNIVERSITY   (Japan)

Author keywords

Kaempferol glycoside; Methicillin resistant Staphylococcus aureus; Norfloxacin; Synergistic effect; Topoisomerase IV

Indexed keywords

CIPROFLOXACIN; ENOXACIN; GLYCOSIDE; KAEMPFEROL; KAEMPFEROL 3 O ALPHA LEVO ( 2' E P COUMAROYL 4' Z P COUMAROYL) RHAMNOSIDE; KAEMPFEROL 3 O ALPHA LEVO ( 2',4' DI E P COUMAROYL) RHAMNOSIDE; LEVOFLOXACIN; NALIDIXIC ACID; NORFLOXACIN; OFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SPARFLOXACIN; UNCLASSIFIED DRUG; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; DRUG ISOLATION; DRUG PURIFICATION; HYDROPHOBICITY; LAURUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN;

ANTI-BACTERIAL AGENTS; COUMARIC ACIDS; DRUG SYNERGISM; FLUOROQUINOLONES; GLYCOSIDES; KAEMPFEROLS; LAURUS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS;

EID: 63149134318     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.32.489     Document Type: Article

References (27)

1. Rice L. B., Am. J. Infect. Control, 34, S11-S19 (2006).
2. Grundmann H., Aires-de-Sousa M., Boyce J., Tiemersma E., Lancet, 368, 874-885 (2006).
3. Klevens R. M., Tokars J. I., Edwards J., Horan T., Infect. Control Hosp. Epidemiol., 27, 338-342 (2006).
4. Aucken H. M., Ganner M., Murchan S., Cookson B. D., Johnson A. P., J. Antimicrob. Chemother., 50, 171-175 (2002).
5. CDC MMWR weekly Report, 51, 565-567 (2002).
6. Mahamoud A., Chevalier J., Alibert-Franco S., Kern W. V., Pagès J. M., J. Antimicrob. Chemother., 59, 1223-1229 (2007).
7. Wright G. D., Sutherland A. D., Trends Mol. Med., 13, 260-267 (2007).
8. Otto M., FEMS Microbiol. Lett., 241, 135-141 (2004).
9. Maresso A. W., Schneewind O., Pharmacol. Rev., 60, 128-141 (2008).
10. Shiota S., Shimizu M., Mizushima T., Ito H., Hatano T., Yoshida T., Tsuchiya T., Biol. Pharm. Bull., 22, 1388-1390 (1999).
11. Shiota S., Shimizu M., Mizusima T., Ito H., Hatano T., Yoshida T., Tsuchiya T., FEMS Microbial. Lett., 185, 135-138 (2000).
12. Shiota S., Shimizu M., Sugiyama J., Morita Y., Mizushima T., Tsuchiya T., Microbiol. Immunol., 48, 67-73 (2004).
13. Shimizu M., Shiota S., Mizushima T., Ito H., Hatano T., Yoshida T., Tsuchiya T., Antimicrob. Agents Chemother., 45, 3198-3201 (2001).
14. Matsuhashi M., Song M. D., Ishino F., Wachi M., Doi M., Inoue M., Ubukata K., Yamashita N., Konno M., J. Bacteriol., 167, 975-980 (1986).
15. Fujita M., Shiota S., Kuroda T., Hatano T., Yoshida T., Mizushima T., Tsuchiya T., Microbiol. Immunol., 49, 391-396 (2005).
16. Otsuka N., Liu M. H., Shiota S., Ogawa W., Kuroda T., Hatano T., Tsuchiya T., Biol. Pharm. Bull., 31, 1794-1797 (2008).
17. Kuroda M., Ohta T., Uchiyama I., Baba T., Yuzawa H., Kobayashi I., Cui L., Oguchi A., Aoki K., Nagai Y., Lian J., Ito T., Kanamori M., Matsumaru H., Maruyama A., Murakami H., Hosoyama A., Mizutani-Ui Y., Takahashi N. K., Sawano T., Inoue R., Kaito C., Sekimizu K., Hirakawa H., Kuhara S., Goto S., Yabuzaki J., Kanehisa M., Yamashita A., Oshima K., Furuya K., Yoshino C., Shiba T., Hattori M., Ogasawara N., Hayashi H., Hiramatsu K., Lancet, 357, 1225-1240 (2001).
18. Shafer W. M., Iandolo J. J., Infect. Immun., 25, 902-911 (1979).
19. Japanese Society of Chemotherapy, Chemotherapy, 38, 102-105 (1990).
20. Eliopoulos G. M., Moellering R. C., "Antibiotics in Laboratory Medicine," 3rd ed., ed. by Lorian V., The Williams & Wilkins Co., Baltimore, 1991, pp. 432-492.
21. Clinical and Laboratory Standards Institute (CLSI), "Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically; Approved Standard (MA7-A7)," 7th ed., Vol. 27, Clinical and Laboratory Standards Institute, Wayne, 2007, p. 113.
22. Takei M., Fukuda H., Kishii R., Hosaka M., Antimicrob. Agents Chemother., 45, 3544-3547 (2001).
23. Bernard F. X., Sablé S., Cameron B., Provost J., Desnottes J. F., Crouzet J., Blanche F., Antimicrob. Agents Chemother., 41, 992-998 (1997).
24. Plaper A., Golob M., Hafner I., Oblak M., Solmajer T., Jerala R., Biochem. Biophys. Res. Commun., 306, 530-536 (2003).
25. Gradisar H., Pristovsek P., Plaper A., Jerala R., J. Med. Chem., 50, 264-271 (2007).
26. Fujimoto-Nakamura M., Ito H., Oyamada Y., Nishino T., Yamagishi J., Antimicrob. Agents Chemother., 49, 3810-3815 (2005).
27. Lewin C. S., Howard B. M., Smith J. T., J. Med. Microbiol., 35, 358-362 (1991).